TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07363161: BASKET BALL - a Prospective, Multicenter, International, Open-label, Randomized Clinical Trial Comparing the Sirolimus-DCB Strategy vs. DES Strategy in de Novo High-risk Patients

Sponsor: B. Braun Melsungen AG · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 2184 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$10,624,000

Rescue Site Savings

+$7,005,200

Unlock Full NCT07363161 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07363161 Rescue Dossier →